World Sleep Industry ENCYCLOPEDIA

spine date seed (Suan zao ren) pastes and powders

3.1.3

Ingredient identity and dosage-form boundaries

Suan zao ren is the dried seed from the mature fruit of the wild or sour jujube in the buckthorn family. A common pharmacopoeial source name is Ziziphus jujuba Mill. var. spinosa (Bunge) Hu ex H.F.Chou; current botanical taxonomy may treat it as Z. jujuba subsp. spinosa. It is not jujube fruit flesh, the hard endocarp around the seed, seed of Indian jujube Z. mauritiana, or an unspecified mixture sold under a similar date-seed name. A specification should identify the seed as the part used and lock the botanical source to the applicable pharmacopoeia or food-medicine list.

Suan zao ren powder may be raw whole-seed powder, powder after stir-baking, defatted meal, concentrated aqueous or alcoholic extract powder, or only a minor ingredient in a blended drink powder. A paste may be a concentrated aqueous extract or a syrup containing honey, malt syrup, sucrose, starch, oilseeds, lily bulb, poria, or other herbs. Whole powder, extract powder, and sweetened paste are not equivalent in fatty oil, saponins, flavonoids, sugar, serving mass, or bioavailability, and cannot be converted by product name alone.

Raw material, processing, and actual dose

The label and specification should state finished-product mass per serving, the amount of seed charged or extract actually present, raw-material equivalence, daily servings, whether raw or stir-baked seed was used, extraction solvent, carriers, and all ingredients. A claim such as 10:1 or high-strength extract is meaningful only when starting-material mass, extraction yield, carrier fraction, and finished-product testing are traceable. Calling a spoonful of paste or one sachet equivalent to a stated mass of herb is insufficient by itself to define exposure.

Stir-baking changes moisture, aroma, seed-coat brittleness, and the extraction or transformation of some constituents. Different temperatures and endpoints produce different fingerprints; processing does not automatically make the material stronger or safer. Whole-seed powder retains more fatty oil and insoluble matter. An aqueous paste mainly represents the fraction transferred by that process, while spray drying can add carriers such as maltodextrin. Spinosin, jujuboside A, or total saponins can characterize lots, but one marker neither represents the full mixture nor independently demonstrates a sleep effect.

Human evidence related to sleep

The randomized trial most closely resembling a single-seed preparation was only a double-blind crossover feasibility study in 12 adults with chronic insomnia. Participants took 2 g of aqueous granules daily for four weeks in each period. PSQI differed statistically from placebo, but the study had period effects, other between-treatment outcomes were not significant, and its primary purpose was to test feasibility. It cannot establish an effective dose for commercial whole-seed powder, stir-baked powder, or paste, or demonstrate long-term benefit.

A 2022 four-week double-blind placebo-controlled trial in 85 people studied a multi-herb Zao Ren An Shen capsule containing suan zao ren. The between-group difference in insomnia severity was only 0.7 points and was neither statistically nor clinically significant; sleep-diary and actigraphic outcomes also showed no clear advantage. A 2023 review included nine trials and 905 participants and found an overall short-term signal in patient-reported sleep quality, but interventions were diverse formulas in which suan zao ren was a key ingredient. Samples were small, quality varied, long-term results were mixed, and evidence relied mainly on subjective scales. Studies of Suanzaoren decoction, Zao Ren An Shen formulas, or adjunctive use with medicines cannot be disassembled into efficacy for a single-ingredient paste or powder.

Mechanistic evidence and limits of extrapolation

The seed contains triterpenoid saponins, flavonoids, fatty acids, alkaloids, and other constituents; jujubosides and spinosin are frequently studied. Cellular and animal experiments propose GABA, serotonin, stress, and inflammatory pathways, but often use isolated compounds or high-dose extracts. They cannot directly predict sleep onset, awakenings, deep sleep, or next-day function after a person consumes one spoonful of paste or powder. Barbiturate-induced sleeping time in an animal is not a human insomnia outcome.

Traditional use helps define historical practice and formula context but does not replace a randomized trial of the finished product. Poria, anemarrhena, Sichuan lovage, licorice, schisandra, and other ingredients in formulas each introduce separate effects and risks, so formula results cannot be assigned wholly to suan zao ren. Short-term self-reported PSQI or ISI changes, actigraphic estimates, and polysomnographic sleep architecture are different endpoints. Anti-anxiety, antioxidant, or neurotransmitter findings cannot be rewritten as proven increases in deep sleep.

Authentication, quality, and process control

Intact seeds can be assessed with macroscopic and microscopic methods. After milling, microscopy, a suitable DNA method, and chromatographic fingerprinting should be combined for authentication. DNA may be degraded in highly processed extracts, increasing the importance of raw-material records, supply-chain traceability, and chemical profiles. Indian jujube seed, hovenia seed, and other similar seeds are recognized substitution or adulteration concerns. Color, bitterness, provenance stories, and a low price do not authenticate the material. Spinosin, jujubosides A and B, and fatty-acid profiles can support identity and lot consistency but do not replace orthogonal methods.

Because the seed is oil-rich, powders require controls for moisture, water activity, particle size, blend uniformity, net content, rancidity-related measures, microorganisms, and sealed light-protected storage. Pastes also need controls for soluble solids, pH, water activity, filling, closure integrity, preservation, and stability after opening. Raw materials and finished products should be tested as applicable for aflatoxins, molds and yeasts, pesticide residues, toxic elements, and foreign material. Research shows that postharvest piling, shell breaking, washing, and damp storage can amplify fungal and aflatoxin hazards. Stir-baking or household preparation does not replace source control and lot testing.

Selection, trial use, and safety boundaries

First distinguish a conventional food, health food, Chinese herbal decoction piece, proprietary medicine, or dietary supplement. Then check the botanical source, plant part, raw or stir-baked status, powder or extract form, formula proportions, amount per serving, lot testing, and responsible business. Total sugar, added sugar, and energy in a paste count for people managing diabetes or energy intake; the word herbal on the front label does not remove them. Honey, nuts, sesame, milk, grains, and other botanicals in a blend also require ingredient-by-ingredient allergy and contraindication review. Moldy or rancid odor, damp clumps, or insects in powder, and a swollen cap, leaking, gas, or abnormal separation in paste are reasons not to consume it.

Short trials and formula studies have reported softer stool, diarrhea, dyspepsia, dry mouth, dizziness, morning sleepiness, rash, sweating, or urinary urgency, but they cannot precisely estimate rates for a single-ingredient paste or powder. A first trial should not coincide with alcohol, multiple sleep supplements, or an unsupervised change in sedative medicine. Anyone who becomes drowsy or slower to respond should not drive or operate hazardous equipment. Clinical interaction evidence is limited; people using hypnotics, antidepressants, anticoagulants, or narrow-therapeutic-index medicines should have the complete formula reviewed by a physician or pharmacist. Finished-product safety is inadequately characterized for pregnancy, breastfeeding, children, liver or kidney disease, and the perioperative period, so traditional use or online anecdotes should not justify prolonged self-treatment.

Regulatory communication and referral

In China, suan zao ren is included among substances traditionally used both as food and Chinese materia medica, but food eligibility does not allow a conventional food to claim improvement of sleep or treatment of insomnia. Conventional foods may not claim health functions or disease prevention and treatment. A registered health food may communicate only its approved function, intended population, and label conditions and cannot replace medicine. A decoction piece or proprietary Chinese medicine remains subject to the applicable medicine quality, prescribing, and labeling rules. Cross-border sellers must reassess ingredient eligibility, dosage form, and claims in the destination market.

Communication should distinguish single ingredient from formula, raw from stir-baked material, whole powder from extract, and short-term subjective scales from objective sleep, while disclosing dose and lot. Natural sleeping pill, zero side effects, one spoon replaces sleeping medicine, and animal mechanisms presented as clinical guarantees are not defensible. Insomnia on several nights each week, meaningful daytime impairment, snoring or gasping, restless legs, unusual nighttime behavior, or an emotional crisis calls for professional assessment. Structured cognitive behavioral therapy for insomnia remains first-line non-drug care for chronic insomnia; an herbal paste or powder should not delay evaluation or replace validated treatment.